Kardia Mobile AC-009Recalls & reported problems
Alivecor, Inc. · KardiaMobile is a personal EKG device that is capable of recording a Single-Lead EKG. It has two electrodes on the top surface and is powered by a replaceable battery located on the back of the device. Ultrasonic transmission is used to wirelessly transmit EKG data from the device to your smartphone or tablet. · Class 2
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI B210AC0090), received between May 22, 2020 and Jul 1, 2020 — classified as 2 injuries.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings2
Patient problems
- Myocardial Infarction2
- Chest Pain1
- Neck Pain1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJul 1, 2020Incorrect, Inadequate or Imprecise Result or Readings
USER CONTACTED ALIVECOR ON (B)(6) 2020 STATING THAT HE USED HIS KARDIAMOBILE 1L TO TAKE AN EKG AND RECEIVED A NORMAL SINUS RHYTHM DETERMINATION WHILE EXPERIENCING A HEART ATTACK. THE SPECIFIC COMMENTS FROM THE PATIENT NOTES THAT "STILL RECOVERING FROM HEART ATTACK ON (B)(6). I USED THIS DEVICE 2 MINUTES PRIOR TO CALLING AMBULANCE AND DEVICE SAID EVERYTHING WAS FINE WITH MY HEART. SUFFERED MAJOR HEART ATTACK THAT MORNING."
Patient problems: Myocardial Infarction
MAUDE report 10217486 ↗InjuryMay 22, 2020Incorrect, Inadequate or Imprecise Result or Readings
PATIENT CONTACTED ALIVECOR ON (B)(6) 2020 STATING THAT SHE USED KARDIAMOBILE TO TAKE EKG AND RECEIVED NORMAL SINUS RHYTHM DETERMINATION WHILE EXPERIENCING A HEART ATTACK. THE SPECIFIC COMMENTS FROM THE PATIENT NOTES THAT "ON (B)(6), I STARTED HAVING CHEST PAIN, LEFT ARM/SHOULDER PRESSURE/PAIN, NECK AND JAW PAIN. I HAD NOT USED THE KARDIA UNIT IN A WHILE AND HAD TO UPDATE THE APP ON MY PHONE. AFTER MORE THAN FEW ATTEMPTS I GOT A READING THAT SAID NORMAL EKG."
Patient problems: Chest Pain; Myocardial Infarction; Neck Pain
MAUDE report 10084224 ↗
Other Transmitters And Receivers, Electrocardiograph, Telephone devices
- MAC 5 A4Ge Medical Systems Information Technologies, Inc. · TRANSMITTERS AND RECEIVERS, ELECTROCARDIOGRAPH, TELEPHONE1 recall0 reports
- AfibAlert / hom ecg+ V2.0Lohman Technologies, LLC · Transmitters And Receivers, Electrocardiograph, Telephone18 reports
- LifeWatch Mobile Cardiac Telemetry 1 Lead Patch MCT 1L Patch-Universal Gateway-VerizonLifewatch · Transmitters And Receivers, Electrocardiograph, Telephone3 reports
- LifeWatch Mobile Cardiac Telemetry 3-Lead MCT 3L-Universal Gateway-VerizonLifewatch · Transmitters And Receivers, Electrocardiograph, Telephone3 reports
- LifeWatch Mobile Cardiac Telemetry 3-Lead MCT 3L-InternationalLifewatch · Transmitters And Receivers, Electrocardiograph, Telephone3 reports
- Rhythm Express RX-1 miniVivaquant, Inc. · Transmitters And Receivers, Electrocardiograph, Telephone2 reports
- LifeWatch Mobile Cardiac Telemetry 3-Lead MCT 3L-Brigadier-VerizonLifewatch · Transmitters And Receivers, Electrocardiograph, Telephone1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page